ARCHIVES

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

This article is from The Cancer Letter archive.

Vol. 40 No. 22 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer

March 28, 2003

NCI Releases 550 Pages of Internal Documents Related To Duke Scandal

January 7, 2011

New Design For NCI’s CancerNet Wins Prestigious Web Site Design Awards.

November 17, 2000

Budget Resolution Includes Extra Money For NCI

July 2, 1982

NCI “Can’t Justify Size Of Intramural Program”

May 12, 1995

RFA For Patterns Of Care Studies Announced By DCCR

November 10, 1978